218 studies found for:    Open Studies | "Colitis, Ulcerative"
Show Display Options
Rank Status Study
21 Unknown  Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Procedure: Colonoscopy biopsy;   Other: stool collection;   Procedure: colonoscopy biopsy
22 Recruiting Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Intervention: Biological: Fecal Microbiota Transplantation
23 Unknown  Role of Healthy Bacteria in Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Other: Control;   Drug: Probiotic
24 Recruiting Standardized Fecal Microbiota Transplantation for Ulcerative Colitis
Conditions: Bacteria;   Microbiota;   Fecal Microbiota Transplantation;   Inflammatory Bowel Disease;   Ulcerative Colitis
Interventions: Procedure: Standardized Fecal Microbiota Transplantation;   Drug: Traditional treatments according to associated guidelines
25 Unknown  Safety, Tolerability, Biomarker and Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis
Conditions: Left-Sided Ulcerative Colitis;   Proctosigmoiditis
Interventions: Drug: PUR 0110 Rectal Enema 250 mg;   Drug: PUR 0110 Rectal Enema 500 mg;   Drug: PUR 0110 Rectal Enema 1000 mg;   Drug: Placebo Enema
26 Recruiting Long-Term Safety Of PF-00547659 In Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: PF-00547659
27 Recruiting FMT in Ulcerative Colitis-Associated Pouchitis
Condition: Ulcerative Colitis Associated Pouchitis
Interventions: Biological: biologically active human fecal microbiota;   Procedure: sigmoidoscopy
28 Not yet recruiting Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Other: Probiotics in the form of cheese portion
29 Not yet recruiting Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis
Conditions: Inflammatory Bowel Diseases;   Ulcerative Colitis
Interventions: Biological: Fecal Microbiota Transplant;   Biological: Placebo
30 Recruiting A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Placebo;   Drug: CP690,550;   Drug: CP-690,550
31 Unknown  Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Dexamethasone 21-phosphate
32 Recruiting Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Apremilast;   Drug: Placebo
33 Recruiting Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: UCMSC group;   Other: Control group(Normal saline)
34 Recruiting Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: Adalimumab;   Other: Placebo
35 Unknown  Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Allogeneic adipose tissue-derived mesenchymal stem cells
36 Not yet recruiting Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Biological: QBECO
37 Unknown  Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Adalimumab
38 Recruiting A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Intervention:
39 Recruiting Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Device: Virtual chromoendoscopy;   Procedure: Chromoendoscopy
40 Recruiting Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab
Condition: Ulcerative Colitis
Intervention: Drug: Golimumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years